Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
1.060
-0.040 (-3.64%)
Jan 30, 2026, 4:00 PM EST - Market closed
Citius Oncology Market Cap
Citius Oncology has a market cap or net worth of $93.57 million as of January 30, 2026. Its market cap has increased by 13.72% in one year.
Market Cap
93.57M
Enterprise Value
93.45M
1-Year Change
13.72%
Ranking
Category
Stock Price
$1.06
Market Cap Chart
Since December 8, 2022, Citius Oncology's market cap has increased from $90.21M to $93.57M, an increase of 3.72%. That is a compound annual growth rate of 1.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 93.57M | 10.35% |
| Dec 31, 2025 | 84.80M | 3.05% |
| Dec 31, 2024 | 82.29M | -15.88% |
| Dec 29, 2023 | 97.81M | 7.68% |
| Dec 30, 2022 | 90.84M | 0.69% |
| Dec 8, 2022 | 90.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Organigram Global | 214.78M |
| Alpha Teknova | 158.98M |
| Anika Therapeutics | 131.67M |
| Cardiol Therapeutics | 108.67M |
| Incannex Healthcare | 108.47M |
| Assertio Holdings | 75.78M |
| Cumberland Pharmaceuticals | 57.28M |
| InterCure | 50.99M |